(Q36705908)

15 August 2017

1 reference

title

When should antiretroviral therapy for HIV be started? (English)

1 reference

15 August 2017

anti-retroviral agent

0 references

3

Nathan Clumeck

1 reference

15 August 2017

1

Andrew N Phillips

1 reference

15 August 2017

5

Jens D Lundgren

1 reference

15 August 2017

Brian G Gazzard

2

1 reference

PMCID

1767243

15 August 2017

Marcelo H Losso

series ordinal

4

1 reference

PMCID

1767243

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

334

1 reference

15 August 2017

7584

1 reference

15 August 2017

76-78

1 reference

CD4+ count-guided interruption of antiretroviral treatment

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Antiretroviral-therapy-associated lipoatrophy: current status and future directions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

The case for earlier treatment of HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

The case for conservative management of early HIV disease.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Treat HIV-1 infection like other infections--treat it.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Combination antiretroviral therapy and the risk of myocardial infarction

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Factors Associated with the Development of Opportunistic Infections in HIV‐1–Infected Adults with High CD4+Cell Counts: A EuroSIDA Study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767243

When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17218713

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17218713

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.39064.406389.94

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

PMCID

1767243